Back

The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Pharmacology and pharmacotherapy e-posters Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

57 More presentations in this session

Presentation thumbnail
Efficacy of propafenone vs. amiodarone in pharmacological cardioversion of recent-onset atrial fibrillation to sinus rhythm: a pooled meta-analysis of 9 randomized controlled trials
Doctor J. Borovac (Split, HR)
Abstract Slides
Presentation thumbnail
The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus
Doctor A. KANWAL (Valhalla, US)
Abstract Slides
Presentation thumbnail
Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.
Doctor K. Dzaurova (Moscow, RU)
Abstract Slides
Presentation thumbnail
The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis
Mrs A. Boulmpou (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis
Mrs A. Boulmpou (Nijmegen, NL)
Abstract Slides

Access the full session

Session thumbnail
Pharmacology and pharmacotherapy e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
3 September 2019
thumbnail
Congress Presentation
Total antioxidant status as biomarker in the control of oxidative stress and prevention of early atherogenic immunogenic mechanisms in young people
26 April 2024
thumbnail
Congress Presentation
Effects of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, on lipid profiling in patients with type 2 diabetes
28 August 2020
thumbnail
Congress Presentation
Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources